These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 12920210)
21. Formyl peptide receptor like 1 differentially requires mitogen-activated protein kinases for the induction of glial fibrillary acidic protein and interleukin-1alpha in human U87 astrocytoma cells. Kam AY; Tse TT; Kwan DH; Wong YH Cell Signal; 2007 Oct; 19(10):2106-17. PubMed ID: 17643960 [TBL] [Abstract][Full Text] [Related]
22. NADPH-oxidase-dependent reactive oxygen species mediate EGFR transactivation by FPRL1 in WKYMVm-stimulated human lung cancer cells. Cattaneo F; Iaccio A; Guerra G; Montagnani S; Ammendola R Free Radic Biol Med; 2011 Sep; 51(6):1126-36. PubMed ID: 21708247 [TBL] [Abstract][Full Text] [Related]
23. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor. Dahlgren C; Christophe T; Boulay F; Madianos PN; Rabiet MJ; Karlsson A Blood; 2000 Mar; 95(5):1810-8. PubMed ID: 10688842 [TBL] [Abstract][Full Text] [Related]
24. The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide. Fu H; Björkman L; Janmey P; Karlsson A; Karlsson J; Movitz C; Dahlgren C BMC Cell Biol; 2004 Dec; 5(1):50. PubMed ID: 15625007 [TBL] [Abstract][Full Text] [Related]
25. Changes in the ratio between FPR and FPRL1 triggered superoxide production in human neutrophils-a tool in analysing receptor specific events. Fu H; Karlsson J; Björkman L; Stenfeldt AL; Karlsson A; Bylund J; Dahlgren C J Immunol Methods; 2008 Feb; 331(1-2):50-8. PubMed ID: 18166194 [TBL] [Abstract][Full Text] [Related]
26. The chemoattractant Trp-Lys-Tyr-Met-Val-D-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1. Svensson L; Dahlgren C; Wennerås C J Leukoc Biol; 2002 Oct; 72(4):810-8. PubMed ID: 12377951 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1. Zhou C; Zhang S; Nanamori M; Zhang Y; Liu Q; Li N; Sun M; Tian J; Ye PP; Cheng N; Ye RD; Wang MW Mol Pharmacol; 2007 Oct; 72(4):976-83. PubMed ID: 17652444 [TBL] [Abstract][Full Text] [Related]
28. A peptide with unique receptor specificity: stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils. Seo JK; Choi SY; Kim Y; Baek SH; Kim KT; Chae CB; Lambeth JD; Suh PG; Ryu SH J Immunol; 1997 Feb; 158(4):1895-901. PubMed ID: 9029131 [TBL] [Abstract][Full Text] [Related]
29. The neuropeptide pituitary adenylate cyclase activating polypeptide modulates Ca2+ and pro-inflammatory functions in human monocytes through the G protein-coupled receptors VPAC-1 and formyl peptide receptor-like 1. El Zein N; Badran B; Sariban E Cell Calcium; 2008 Mar; 43(3):270-84. PubMed ID: 17651798 [TBL] [Abstract][Full Text] [Related]
30. Differential production of leukotriene B4 or prostaglandin E2 by WKYMVm or serum amyloid A via formyl peptide receptor-like 1. Lee HY; Jo SH; Lee C; Baek SH; Bae YS Biochem Pharmacol; 2006 Sep; 72(7):860-8. PubMed ID: 16859643 [TBL] [Abstract][Full Text] [Related]
31. The synthetic chemoattractant peptide, Trp-Lys-Tyr-Met-Val-D-Met, enhances monocyte survival via PKC-dependent Akt activation. Bae YS; Kim Y; Park JC; Suh PG; Ryu SH J Leukoc Biol; 2002 Feb; 71(2):329-38. PubMed ID: 11818455 [TBL] [Abstract][Full Text] [Related]
32. T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors. Su SB; Gao Jl; Gong Wh; Dunlop NM; Murphy PM; Oppenheim JJ; Wang JM J Immunol; 1999 May; 162(10):5924-30. PubMed ID: 10229829 [TBL] [Abstract][Full Text] [Related]
34. Lipoxin A4 elevates cytosolic calcium in human neutrophils. Moores KE; Merritt JE Eicosanoids; 1991; 4(2):89-94. PubMed ID: 1910866 [TBL] [Abstract][Full Text] [Related]
35. VIP differentially activates beta2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1. El Zein N; Badran B; Sariban E J Leukoc Biol; 2008 Apr; 83(4):972-81. PubMed ID: 18174366 [TBL] [Abstract][Full Text] [Related]
37. Characterization of human neutrophil and endothelial cell ligand-operated extracellular acidification rate by microphysiometry: impact of reoxygenation. Gronert K; Colgan SP; Serhan CN J Pharmacol Exp Ther; 1998 Apr; 285(1):252-61. PubMed ID: 9536019 [TBL] [Abstract][Full Text] [Related]
38. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels. Karlsson J; Stenfeldt AL; Rabiet MJ; Bylund J; Forsman HF; Dahlgren C Cell Calcium; 2009 May; 45(5):431-8. PubMed ID: 19282028 [TBL] [Abstract][Full Text] [Related]
39. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met as a novel adjuvant for DNA vaccine. Lee CG; Choi SY; Park SH; Park KS; Ryu SH; Sung YC Vaccine; 2005 Sep; 23(38):4703-10. PubMed ID: 15936851 [TBL] [Abstract][Full Text] [Related]
40. PKC-delta controls the fMLF-induced overproduction of superoxide by neutrophils. Matron C; Chakravarti A; Allaeys I; Poubelle PE Free Radic Biol Med; 2010 Jan; 48(2):207-15. PubMed ID: 19854263 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]